Edition:
India

Immune Pharmaceuticals Inc (IMNP.OQ)

IMNP.OQ on NASDAQ Stock Exchange Capital Market

0.35USD
1:30am IST
Change (% chg)

$-0.02 (-4.27%)
Prev Close
$0.37
Open
$0.35
Day's High
$0.36
Day's Low
$0.34
Volume
69,460
Avg. Vol
217,072
52-wk High
$3.43
52-wk Low
$0.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.695
Sep '17 0.00 -0.534
Jun '17 0.00 -0.500
Mar '17 0.00 -0.427
FY 2016 Dec '16 0.00 -1.538
Sep '16 0.00 -3.139
Jun '16 0.00 -2.659
Mar '16 0.00 -3.486
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 1 -0.21 -0.21 -0.21 --
Quarter Ending Sep-18 1 -0.09 -0.09 -0.09 --
Year Ending Dec-18 1 -0.51 -0.51 -0.51 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.95 32.74
P/E High - Last 5 Yrs. -- 40.70 45.72
P/E Low - Last 5 Yrs. -- 23.63 24.22
Beta 2.17 0.89 0.88
Price to Sales (TTM) -- 3.94 5.71
Price to Book (MRQ) -- 4.80 5.37
Price to Tangible Book (MRQ) -- 5.61 6.95
Price to Cash Flow (TTM) -- 22.91 23.32
% Owned Institutions 5.00 1.21 2.17

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.47 5.32
Payout Ratio(TTM) -- 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.69 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 4.83 5.69
Sales - 5 Yr. Growth Rate -- 10.08 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 81.21 16.36 19.36
EPS (TTM) vs TTM 1 Yr. Ago 69.50 -- --
EPS - 5 Yr. Growth Rate -- 9.87 10.76
Capital Spending - 5 Yr. Growth Rate -4.18 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.12 2.19
Current Ratio (MRQ) 0.02 2.90 2.98
LT Debt to Equity (MRQ) -- 9.88 12.18
Total Debt to Equity (MRQ) -- 13.86 16.45
Interest Coverage (TTM) -7.64 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.81 54.44
Gross Margin - 5 Yr. Avg. -- 52.15 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -301,733.31 18.57 10.96
Operating Margin (TTM) -- 14.36 4.73
Operating Margin - 5 Yr. Avg. -343,366.69 14.52 6.40
Pre-Tax Margin (TTM) -- 14.82 5.57
Pre-Tax Margin - 5 Yr. Avg. -459,700.00 14.90 6.81
Net Profit Margin (TTM) -- 11.07 1.87
Net Profit Margin - 5 Yr. Avg. -436,680.91 11.20 3.09
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.42 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 938,079,907 846,829,796
Net Income/Employee (TTM) -3,618,000 110,368,362 99,616,056
Receivable Turnover (TTM) -- 5.63 5.78
Inventory Turnover (TTM) -- 2.59 3.35
Asset Turnover (TTM) 0.00 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -120.00 11.40 10.95
Return on Assets - 5 Yr. Avg. -74.56 12.91 12.31
Return on Investment (TTM) -201.88 14.84 14.38
Return on Investment - 5 Yr. Avg. -109.15 16.88 16.10
Return on Equity (TTM) -1,487.29 16.34 16.07
Return on Equity - 5 Yr. Avg. -477.80 17.98 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 46.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Immune Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.16%
# of Holders: 16
Total Shares Held: 688,328
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.